Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
The Lancet. Child & Adolescent Health|September 1, 2018
Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trialEva Natukunda, Aditya H Gaur, Pope Kosalaraksa, et al.
Journal of Clinical Pharmacology|September 26, 2018
Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through AdulthoodJincheng Yang, Mina Nikanjam, Brookie M Best, et al.
AIDS Research and Human Retroviruses|September 9, 2021
Metabolomics in Placental Tissue from Women Living with HIVHuda B Al-Kouatly, Rachel K Scott, Mona M Makhamreh, et al.
JMIR Serious Games|October 17, 2018
Digital Gaming to Improve Adherence Among Adolescents and Young Adults Living With HIV: Mixed-Methods Study to Test Feasibility and AcceptabilityAmanda D Castel, Saba Qasmieh, Daniel Greenberg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 31, 2011
Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in childrenBrookie M Best, Edmund V Capparelli, Huy Diep, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2024
Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of AmericaMichael Horberg, Melanie Thompson, Allison Agwu, et al.
Plos One|February 10, 2017
"It Makes You Feel Like Someone Cares" acceptability of a financial incentive intervention for HIV viral suppression in the HPTN 065 (TLC-Plus) studyElizabeth Greene, Allison Pack, Jill Stanton, et al.
Plos One|December 2, 2021
Supporting adolescents living with HIV within boarding schools in KenyaJudith Kose, Cosima Lenz, Job Akuno, et al.
Journal of the International AIDS Society|January 31, 2025
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kgEva Natukunda, Aditya H Gaur, Pope Kosalaraksa, et al.
The Journal of Pediatrics|January 26, 2019
A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug AdministrationXiaomei I Liu, Paul Schuette, Gilbert J Burckart, et al.
Pageof 7